SCHEMBL3880467

SCHEMBL3880467

N#C[C@H](O)c1cccc(Oc2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.60
PTGS1 P23219 1/20 0.53
AKR1C3 P42330 1/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
CYP2D6 P10635 1/20 0.51
ALOX5 P09917 1/20 0.49
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
MAOB P27338 1/20 0.43
HDAC8 Q9BY41 1/20 0.42
LTA4H P09960 1/20 0.41
NPC1 O15118 1/20 0.41
NPY5R Q15761 1/20 0.40
CCR1 P32246 1/20 0.40
SGMS2 Q8NHU3 1/20 0.40
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30045078 1.00 TSHR (0.60) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL29890128 1.00 TSHR (0.60) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL192456 1.00 TSHR (0.60) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL1677135 1.00 TSHR (0.60) TSHRPTGS1AKR1C3MEN1KMT2A
Alcohol SCHEMBL9863179 0.92 TSHR (0.51) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL11424402 0.89 TSHR (0.47) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL359346 0.87 TSHR (0.44) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL10507535 0.87 TSHR (0.44) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL5394591 0.87 TSHR (0.44) TSHRPTGS1AKR1C3MEN1KMT2A
SCHEMBL11248942 0.87 TSHR (0.44) TSHRPTGS1AKR1C3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7560585-B2 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-07-14 US claimed
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2006-06-15 US claimed
WO-2006010994-A1 PROCESS FOR PREPARING (S)-ALPHA-CYANO-3-PHENOXYBENZYL-(S)-2-(4-CHLOROPHENYL)-ISOVALERATE COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-02-02 WO claimed
EP-0132392-B1 ASYMMETRIC SYNTHESIS OF ALPHA-SUBSTITUTED-ALPHA-CYANOMETHYL ALCOHOLS ICI AUSTRALIA LIMITED (AU) 1992-01-02 EP claimed
US-4985365-A WITH AN ESTERASE FROM A MICROORGANISM, ASSYMETRIC HYDROLYSIS SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1991-01-15 US claimed
EP-0080827-B1 METHOD FOR BIOTECHNOLOGICALLY PREPARING (S)-(-)-ALPHA-CYANO-3-PHENOXYBENZYL ALCOHOL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-03-09 EP claimed
US-4701542-A Resolution of hemiacetals and alcohols ROUSSEL UCLAF (FR) 1987-10-20 US claimed
EP-0082049-B1 ETHERS WITH CHIRAL ATOMS IN THE ORGANIC REST GROUPS, THEIR PREPARATION, THEIR USE IN THE RESOLUTION OF ALCOHOLS OR OF CERTAIN HEMIACETALS, AND COMPOUNDS SO RESOLVED ROUSSEL-UCLAF (FR) 1987-07-29 EP claimed
EP-0095794-B1 ESTERS OF 2,2-DIMETHYL-3-FORMYL-1-CYCLOPROPANE-CARBOXYLIC ACID ROUSSEL-UCLAF (FR) 1985-09-18 EP claimed
EP-0132392-A2 Asymmetric synthesis of alpha-substituted-alpha-cyanomethyl alcohols ICI AUSTRALIA LIMITED (AU) 1985-01-30 EP claimed
EP-0030887-B1 IMINES DERIVED FROM ESTERS OF 3-FORMYL-CYCLOPROPANE-1-CARBOXYLIC ACIDS, THEIR PREPARATIONS, THEIR USE IN THE PREPARATION OF CORRESPONDING 3-VINYL-SUBSTITUTED ESTERS ROUSSEL-UCLAF (FR) 1984-01-18 EP claimed
EP-0007255-B1 SUBSTITUTED CYCLOPROPANE CARBOXYLIC ACID ESTERS OF ALPHA-CYANATED ALCOHOLS, A PROCESS FOR THEIR PREPARATION, PESTICIDAL COMPOSITIONS CONTAINING THEM, AS WELL AS THEIR USE AS VETERINARY MEDICAMENTS ROUSSEL-UCLAF (FR) 1983-07-06 EP claimed
EP-0080827-A2 Method for biotechnologically preparing (S)-(-)-alpha-cyano-3-phenoxybenzyl alcohol SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-06-08 EP claimed
US-4344895-A ESTERIFICATION, HYDROLYSIS ROUSSEL UCLAF (FR) 1982-08-17 US claimed
US-4312817-A Imino derivatives ROUSSEL UCLAF (FR) 1982-01-26 US claimed
US-4151195-A Novel racemization process ROUSSEL UCLAF (FR) 1979-04-24 US claimed
JP-58212790-A None JP disclosed
JP-2049759-A None JP disclosed
US-4133826-A REACTION OF OPTICALLY ACTIVE OR RACEMIC MIXTURE OF ESTERS WITH BASE ROUSSEL UCLAF (FR) 1979-01-09 US disclosed
JP-S05894389-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128982-A1 Process for preparing (S)- alpha-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-isovalerate PCCA, CHRNE, CHRNB4 TSHR 3108/4885PTGS1 4013/4885AKR1C3 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.